| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.0097 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |